Background Low molecular weight heparin (LMWH),as one of anticoagulant drugs,has been used for the treatment of chronic obstructive pulmonary disease (COPD) wit
Background A number of studies have demonstrated the rates of overall and aneurysm-related mortality and morbidity in West populations.The cardiovascular risk f